PATENT CLAIM ANALYSIS

Application Number: 15866043
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "279000"]

Abstract:
A depot precursor formulation comprising: a) a controlled-release matrix; b) at least oxygen containing organic solvent; c) at least 12% by weigh of at least one active agent selected from buprenorphine and salts thereof, calculated as buprenorphine free base.   Corresponding depot compositions and methods of treatment in pain management, by opioid maintenance and related methods are provided.

Claim (Index 52):
A method of treatment or prophylaxis of a human or non-human animal subject comprising administration of a precursor formulation of  claim 51 .

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14416421', '11798495', '14362517', '11628007', '11795249']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7816754554466258
- 35 USC 102 Novelty (BERT): 0.5901004265610066
- Combined Prediction Score: 0.7625179525580639
- Mean Citation Score: 342.746164
- Max Citation Score: 518.8724
- Similarity Product: 439.5751080145359

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test